Parent and Infant Inter(X)Action Intervention (PIXI) | MicrobiomeTrials← Back to trialsNCT03836300
Parent and Infant Inter(X)Action Intervention (PIXI)
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2018-11-30Est. Completion: 2026-06-30
Enrollment target: 120 participants Locations- RTI International, Research Triangle Park, North Carolina, United States
Other microbiome trials you might be interested in
Neurodevelopmental DisordersAutismAutism Spectrum DisorderFragile X SyndromeTuberous Sclerosis22Q11 Deletion Syndrome22Q11 DeletionADHDTic DisordersTourette SyndromeTourette Syndrome in ChildrenTourette Syndrome in AdolescenceADHD - Combined TypeADHD Predominantly Inattentive TypeADHD, Predominantly Hyperactive - ImpulsiveAnxietyAnxiety Disorders
There are currently no approved medications for the treatment of anxiety in children and youth with neurodevelopmental d…
Calgary, CanadaEst. completion Sep 2027
Fragile X Syndrome (FXS)Fragile X Syndrome
The purpose of this Phase IIa study is to evaluate the safety, tolerability, and effectiveness of CTH120 in adult males …
Barcelona, SpainEst. completion May 2027
Fragile X Syndrome
This study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of…
Phoenix, United StatesEst. completion Oct 2027